Albumin And Creatinine Tests Market Growth Forecast Through 2030: Market Size And Trends In 2026
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Albumin And Creatinine Tests Market Value Growth And Long-Term Outlook
The market size for albumin and creatinine tests has experienced substantial expansion in recent years. It is set to expand from $3.6 billion in 2025 to $4.4 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 22.2%. Contributing factors to its historical growth include the restricted availability of point-of-care testing devices, the continued reliance on manual urine dipstick tests, a rising incidence of kidney-related disorders, the development of hospital and diagnostic laboratory infrastructure, and enhanced public awareness of kidney disease screening.
The albumin and creatinine tests market size is projected to experience substantial expansion in the coming years, reaching $9.65 billion by 2030, driven by a compound annual growth rate (CAGR) of 21.7%. This anticipated growth during the forecast period is attributed to several factors, including technological advancements in urine analyzers and cartridges, the proliferation of automated laboratory solutions, a rising adoption of glycated albumin testing, increased investment in diagnostic reagent innovation, and the integration of data analytics for early kidney disease detection. Key trends foreseen in this period include a wider acceptance of point-of-care albumin and creatinine tests, escalating demand for automated urine analyzers, the broader application of microalbumin test kits for early kidney disease detection, an increasing utilization of colorimetric and immunoassay reagents, and enhanced accuracy through standardized calibration and control solutions.
Get A Free Sample Report With In-Depth Market Insights:
Albumin And Creatinine Tests Market Growth Factors Behind Sustained Expansion
The increasing occurrence of chronic kidney diseases is anticipated to fuel the expansion of the albumin and creatinine tests market in the future. Chronic kidney disease (CKD) describes the progressive decline in kidney function, wherein kidneys lose their ability to efficiently filter waste and excess fluids from the bloodstream, resulting in toxin accumulation and potential complications across different bodily systems. This growing incidence of chronic kidney diseases is propelled by an increase in risk factors like diabetes, hypertension, and obesity. Albumin and creatinine tests are instrumental in diagnosing and monitoring chronic kidney diseases; they measure protein levels, specifically albumin, in urine and evaluate kidney function via creatinine levels, facilitating prompt detection and treatment of kidney damage. For example, a report from Kidney Research UK, a non-profit organization based in the UK, indicated that in June 2023, approximately 7.2 million people in the UK, representing over 10% of the populace, were suffering from chronic kidney disease. Out of these, 3.25 million were in advanced stages and 3.9 million in early stages. Projections suggest that by 2033, the number of affected individuals will rise to 7.61 million. Consequently, the escalating incidence of chronic kidney disease is stimulating the expansion of the albumin and creatinine tests market.
Albumin And Creatinine Tests Market Breakdown By Product Type And Application
The albumin and creatinine tests market covered in this report is segmented –
1) By Product: Dipsticks And Kits, Analyzers, Cartridges, Reagents, Other Products
2) By Test Parameter: Blood And Urine Creatinine, Urine Albumin
3) By End-User: Hospital And Clinics, Diagnostic Laboratories, Research Laboratories And Institutes, Other End-User
Subsegments:
1) By Dipsticks And Kits: Urine Dipstick Tests, Microalbumin Test Kits, Point-of-Care Test Kits
2) By Analyzers: Automated Urine Analyzers, Benchtop Analyzers, Handheld Analyzers
3) By Cartridges: Single-Use Cartridges, Multi-Parameter Cartridges
4) By Reagents: Colorimetric Reagents, Enzymatic Reagents, Immunoassay Reagents
5) By Other Products: Control Solutions, Calibration Standards, Accessories And Consumables
Albumin And Creatinine Tests Market Industry Trends Fueling Future Revenue Growth
Leading companies in the albumin and creatinine tests market are concentrating on developing advanced digital diagnostic solutions, such as smartphone-enabled uACR testing, to enhance the early detection of chronic kidney disease and expand patient access to at-home testing. This smartphone-enabled uACR testing utilizes mobile phone cameras, AI-driven analysis, and test strips to measure the urine albumin-to-creatinine ratio, providing rapid and reliable results without requiring in-clinic visits. For instance, in November 2024, Healthy.io, an Israel-based digital diagnostics company, presented new clinical study findings at ASN Kidney Week 2024, demonstrating that its smartphone-enabled Minuteful Kidney test delivers accuracy comparable to laboratory analyzers for measuring uACR. The study showed that the AI-powered test reliably identified elevated albumin levels and supported early CKD detection, helping reduce barriers to testing and enabling proactive kidney health management.
Albumin And Creatinine Tests Market Company Landscape And Competitive Strategy
Major companies operating in the albumin and creatinine tests market are Siemens Healthineers Company, Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, FUJIFILM Corporation, Laboratory Corporation of America Holdings, Sysmex Corporation, Ortho Clinical Diagnostics Inc., Randox Laboratories Ltd., Nova Biomedical Corporation, Eagle Biosciences Inc., Sekisui Diagnostics LLC, BTNX Inc., RayBiotech Life Inc., ARKRAY Inc., PromoCell GmbH, Arbor Assays Inc., Teco Diagnostics Inc., J. Mitra & Co. Pvt. Ltd., Anamol Laboratories Pvt. Ltd.
View The Full Albumin And Creatinine Tests Market Report:
Albumin And Creatinine Tests Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the albumin and creatinine tests market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the albumin and creatinine tests market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
